[1]赵　杰,朱　萍,苌俊明,等.凝固酶阴性葡萄球菌致新生儿败血症病原学及青霉素联合万古霉素治疗效果分析[J].新乡医学院学报,2022,39(7):673-679.[doi:10.7683/xxyxyxb.2022.07.015]
　ZHAO Jie,ZHU Ping,CHANG Junming,et al.Etiology of neonatal sepsis caused by coagulase-negative Staphylococci and therapeutic effect of penicillin combined with vancomycin[J].Journal of Xinxiang Medical University,2022,39(7):673-679.[doi:10.7683/xxyxyxb.2022.07.015]
点击复制

凝固酶阴性葡萄球菌致新生儿败血症病原学及青霉素联合万古霉素治疗效果分析
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年7
页码:
673-679
栏目:
临床研究
出版日期:
2022-07-05

文章信息/Info

Title:
Etiology of neonatal sepsis caused by coagulase-negative Staphylococci and therapeutic effect of penicillin combined with vancomycin
作者:
赵　杰; 朱　萍; 苌俊明; 别静洋; 李德亮; 王海云; 杨　柳
（南阳市中心医院/郑州大学附属南阳中心医院新生儿重症监护病区，河南　南阳　473005）
Author(s):
ZHAO Jie; ZHU Ping; CHANG Junming; BIE Jingyang; LI Deliang; WAMG Haiyun; YANG Liu
(Neonatal Intensive Care Unit,Nanyang Central Hospital/Nanyang Central Hospital Affiliated to Zhengzhou University,Nanyang 473005,Henan Province,China)
关键词:
凝固酶阴性葡萄球菌; 新生儿败血症; 病原学; 耐药性; 广谱青霉素类; 万古霉素
Keywords:
coagulase-negative Staphylococci; neonatal sepsis; etiology; drug resistance; penicillin; vancomycin
分类号:
R721
DOI:
10.7683/xxyxyxb.2022.07.015
文献标志码:
A
摘要:
目的　探讨凝固酶阴性葡萄球菌（CNS）致新生儿败血症的病原菌分布和耐药性，以及青霉素联合万古霉素治疗CNS致新生儿败血症的疗效。方法　选择2019年1 月至2020年12月南阳市中心医院收治的CNS致新生儿败血症185例为研究对象，根据治疗方法将患儿分为观察组（n=94）和对照组（n=91）。对照组患儿给予注射用青霉素钠静脉滴注，每次50 000 U·kg-1，出生7 d内每12 h 1次，出生第7天后每8 h 1次。观察组在对照组基础上给予万古霉素治疗，第1天给予15 mg·kg-1万古霉素静脉滴注，滴注时间﹥1 h，每日1次；第2天开始给予10 mg·kg-1万古霉素静脉滴注，滴注时间﹥1 h，每日1次。2组患儿均治疗14 d。采用全自动细菌鉴定及药物敏感分析系统进行菌种鉴定和药物敏感性分析，按照《抗菌药物临床研究指导原则》评定临床疗效，应用流式细胞仪检测全血自然杀伤（NK）细胞活性，应用全自动血液细胞分析仪进行白细胞（WBC）计数，应用全自动生物化学分析系统检测血清免疫球蛋白（Ig）G、IgM水平，采用酶联免疫吸附法检测血清肿瘤坏死因子-α（TNF-α）、白细胞介素（IL）-6、IL-8、C 反应蛋白（CRP）水平。结果　185例CNS致新生儿败血症患儿的病原菌前3位分别为表皮葡萄球菌、溶血葡萄球菌、人葡萄球菌，占比分别为40.54%（75/185）、28.11%（52/185）、14.05%（26/185）。表皮葡萄球菌对青霉素、氨苄西林、苯唑西林的耐药性分别为100.00%、97.33%、92.00%，对替考拉宁、万古霉素的敏感性均达100.00%；溶血葡萄球菌对青霉素、氨苄西林、苯唑西林、头孢曲松、红霉素的耐药性分别为100.00%、100.00%、96.15%、94.23%、92.31%，对替考拉宁、万古霉素的敏感性均达100.00%；人葡萄球菌对青霉素、氨苄西林的耐药性分别为100.00%、92.31%，对替考拉宁、万古霉素的敏感性均达100.00%。治疗后，观察组患儿的临床疗效优于对照组（Z=30.179，P<0.05）。观察组和对照组患儿的治疗总有效率分别为 98.94%（93/94）、89.01%（81/91），观察组患儿的治疗总有效率显著高于对照组（χ2=8.145，P<0.05）。观察组和对照组患儿的不良反应发生率分别为19.15%（18/94）、18.68%（17/91），2组患儿的不良反应发生率比较差异无统计学意义（χ2=0.007，P>0.05）。 2组患儿治疗前血清IgG、IgM水平和NK细胞活性比较差异无统计学意义（P>0.05）；2组患儿治疗后血清IgG水平和NK细胞活性显著高于治疗前，血清IgM水平显著低于治疗前（P<0.05）；观察组患儿治疗后血清IgG水平和NK细胞活性显著高于对照组，血清IgM水平显著低于对照组（P<0.05）。治疗前，2组患儿血清TNF-α、IL-6、IL-8、CRP水平及WBC计数比较差异均无统计学意义（P>0.05）；2组患儿治疗后血清TNF-α、IL-6、IL-8、CRP水平及WBC计数显著低于治疗前（P<0.05）；治疗后，观察组患儿血清TNF-α、IL-6、IL-8、CRP水平显著低于对照组（P<0.05）；治疗后，2组患儿WBC计数比较差异无统计学意义（P>0.05）。结论　CNS致新生儿败血症的病原菌以表皮葡萄球菌、溶血葡萄球菌、人葡萄球菌为主，3种CNS中均未检测出对万古霉素耐药菌株；万古霉素联合广谱青霉素治疗可显著提高CNS致新生儿败血症患儿免疫功能，降低炎症反应，提高临床疗效。
Abstract:
Objective　To investigate the pathogenic distribution and drug resistance in children with neonatal sepsis caused by coagulase-negative Staphylococci (CNS),and to analyze the efficacy of penicillin combined with vancomycin in the treatment of neonatal sepsis caused by CNS.Methods　A total of 185 cases of neonatal sepsis caused by CNS admitted to Nanyang Central Hospital from January 2019 to December 2020 were selected as the research subjects,and the children were divided into the observation group(n=94) and the control group (n=91) according to the treatment method.The children in the control group were treated with penicillin intravenously,50 000 U·kg-1 at each time,once every 12 hours within 7 days after birth and once every 8 hours after the 7th day of birth;the children in the observation group was treated with vancomycin on the basis of the control group,15 mg·kg-1 vancomycin was given intravenously on the first day,the time of intravenous drip was more than 1 hour,once a day;from the second day,10 mg·kg-1 vancomycin was given intravenously,the time of intravenous drip was more than 1 hour,once a day.The children in the both groups were treated for 14 days.The strain identification and drug sensitivity was analyzed by using automatic bacterial identification and drug sensitivity analysis system,and the clinical efficacy was evaluated according to the guiding principles for clinical research of antibiotics,the activity of natural killer (NK) cells in whole blood was detected by flow cytometry,the number of white blood cell (WBC) was counted by automatic blood cell analyzer,and the levels of serum immunoglobulin (Ig) G and IgM were detected by automatic biochemical analysis system,and the levels of serum tumor necrosis factor-α(TNF-α),interleukin (IL)- 6,IL-8,C-reactive protein (CRP) were detected by enzyme-linked immunosorbent assay.Results　The constituent ratio of the top three of pathogenic bacteria in 185 children with neonatal sepsis caused by CNS were Staphylococcus epidermidis,Staphylococcus haemolyticus and Staphylococcus hominis,which accounted for 40.54% (75/185),28.11% (52/185) and 14.05% (26/185),respectively.The resistance of Staphylococcus epidermidis to penicillin,ampicillin and oxacillin was 100.00%,97.33% and 92.00%,respectively;its sensitivity to teicoplanin and vancomycin was all of 100.00%.The resistance of Staphylococcus haemolyticus to penicillin,ampicillin,oxacillin,ceftriaxone and erythromycin was 100.00%,100.00%,96.15%,94.23% and 92.31%,respectively;its sensitivity to teicoplanin and vancomycin was all of 100.00%.The resistance of Staphylococcus hominis to penicillin and ampicillin was 100.00% and 92.31%,respectively;its sensitivity to teicoplanin and vancomycin was all of 100.00%.After treatment,the clinical effect of children in the observation group was better than that in the control group (Z=30.179,P<0.05).The total effective rate of children in the observation group and the control group was 98.94% (93/94) and 89.01% (81/91),respectively.The total effective rate of children in the observation group was significantly higher than that in the control group（χ2=8.145,P<0.05）.The incidence of adverse reactions of children in the observation group and the control group was 19.15% (18/94) and 18.68% (17/91).There was no significant difference in the incidence of adverse reactions of children between the two groups(χ2=0.007，P>0.05）.There was no significant difference in the levels of IgG,IgM in serum and NK cell activity of children between the two groups before treatment (P>0.05).The level of IgG in serum and NK cell activity of children after treatment in the two groups were significantly higher than those before treatment,and the level of IgM in serum was significantly lower than that before treatment (P<0.05).The level of IgG in serum and NK cell activity of children after treatment in the observation group were significantly higher than those in the control group,and the level of IgM in serum was significantly lower than that in the control group (P<0.05).There was no significant difference in the levels of TNF-α,IL-6,IL-8,CRP in serum and WBC count of children between the two groups before treatment (P>0.05).After treatment,the levels of TNF-α,IL-6,IL-8,CRP in serum and WBC count of children in the two groups were significantly lower than those before treatment (P<0.05).The levels of TNF-α,IL-6,IL-8,CRP in serum of children in the observation group were significantly lower than those in the control group (P<0.05).There was no significant difference in WBC count of children between the two groups (P>0.05).Conclusion　Staphylococcus epidermidis,Staphylococcus haemolyticus and Staphylococcus hominis are the main pathogens of CNS induced neonatal sepsis.The three main CNS are not resistant to vancomycin.The vancomycin combined with penicillin can significantly improve immune function,reduce inflammatory reaction,and improve clinical effect of children with neonatal sepsis caused by CNS.

参考文献/References:

［1］　BROOK B,HARBESON D J,SHANNON C P,et al.BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsis［J］.Sci Transl Med,2020,12(542):eaax4517.
［2］　杜立中.新生儿败血症诊断和预防面临的挑战［J］.中华儿科杂志,2019,57(4):241-243.
DU L Z.Challenges in diagnosis and prevention of neonatal sepsis［J］.Chin J Pediatr,2019,57(4):241-243.
［3］　陈潇,富建华.新生儿败血症229例临床特点、病原学分布及转归分析［J］.中华实用儿科临床杂志,2019,34(10):740-744.
CHEN X,FU J H.Analysis of clinical features,pathogen distribution and outcome of 229 children with neonatal sepsis［J］.Chin J Appl Clin Pediatr,2019,34(10):740-744.
［4］　刘新光,崔玉娇,吴昊,等.儿童血培养检出菌的构成与凝固酶阴性葡萄球菌在血流感染中的致病性研究［J］.河北医药,2018,40(7):1099-1101.
LIU X G,CUI Y J,WU H,et al.The composition of detection bacteria in blood culture of children patients and the pathogenicity of coagulase-negative Staphylococci in bloodstream infection［J］.Hebei Med J,2018,40(7):1099-1101.
［5］　中华医学会儿科学分会新生儿学组,《中华儿科杂志》编辑委员会.新生儿败血症诊疗方案［J］.中华儿科杂志,2003,41(12):897-899.
THE SUBSPECIALTY GROUP OF NEONATOLOGY,PEDIATRIC SOCIETY,CHINESE MEDICAL ASSOCIATION;THE EDITORIAL BOARD,CHINESE JOURNAL OF PEDIATRICS.Protocol for diagnosis and treatment of neonatal septicemia［J］.Chin J Pediatr,2003,41(12):897-899.
［6］　《抗菌药物临床应用指导原则》修订工作组.抗菌药物临床应用指导原则:2015年版［M］.北京:人民卫生出版社,2015:72.
REVISION WORKING GROUP OF GUIDELINE PRINCIPLES FOR CLINICAL USE OF ANTIBIOTICS.Guideline principles for clinical use of antibiotics(version 2015)［M］.Beijing:People′s Publishing House,2015:72.
［7］　ARGEMI X,HANSMANN Y,PROLA K,et al.Coagulase-negative Staphylococci pathogenomics［J］.Int J Mol Sci,2019,20(5):1215.
［8］　邰世斌,王增强.临床药师参与1例新生儿耐甲氧西林凝固酶阴性葡萄球菌感染的药物治疗实践［J］.中国药师,2019,22(11):2067-2069.
TAI S B,WANG Z Q.Participation of clinical pharmacist in the drug treatment of a neonatal infection with methicillin-resistant coagulase negative Staphylococcus［J］.China Pharmacist,2019,22(11):2067-2069.
［9］　HIROSE M,AUNG M S,FUKUDA A,et al.Prevalence and genetic characteristics of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococci isolated from oral cavity of healthy children in Japan［J］.Microb Drug Resist,2019,25(3):400-407.
［10］　CUI J,LIANG Z,MO Z,et al.The species distribution,antimicrobial resistance and risk factors for poor outcome of coagulase-negative Staphylococci bacteraemia in China［J］.Antimicrob Resist Infect Control,2019,8:65.
［11］　王岩青.凝固酶阴性葡萄球菌胞外黏质物检测及临床意义的探讨［J］.中国社区医师(医学专业),2011,13(35):224-225.
WANG Y Q.Detection of extracellular mucus of coagulase negative Staphylococcus and its clinical significance［J］.Chin Commun Doctors,2011,13(35):224-225.
［12］　胡丹辰,孙争辉,孙建斌,等.凝固酶阴性葡萄球菌感染患者临床特征及万古霉素药效学分析［J］.中华医院感染学杂志,2020,30(1):20-24.
HU D C,SUN Z H,SUN J B,et al.Clinical characteristics of patients with coagulase-negative Staphylococcus infection and pharmacodynamics of vancomycin［J］.Chin J Nosocomiol,2020,30(1):20-24.
［13］　李志博,马友凤,谷献芳,等.万古霉素治疗新生儿凝固酶阴性葡萄球菌感染的疗效及肾毒性观察［J］.中华医院感染学杂志,2018,28(1):132-134.
LI Z B,MA Y F,GU X F,et al.Efficacy of vancomycin in treatment of neonates with coagulase-negative Staphylococcus infections and renal toxicity observation［J］.Chin J Nosocomiol,2018,28(1):132-134.
［14］　郑旭婷,陈佰义.万古霉素敏感性下降的金黄色葡萄球菌的临床意义及对策［J］.实用临床医药杂志,2019,23(9):119-123.
ZHENG X T,CHEN B Y.Clinical significance of Staphylococcus aureus with decreased vancomycin sensitivity and countermeasures［J］.J Clin Med Pract,2019,23(9):119-123.
［15］　卢婷,王模奎.维生素D治疗新生儿早发型败血症的临床研究［J］.药物评价研究,2020,43(12):2493-2497.
LU T,WANG M K.Clinical study on vitamin D in treatment of premature sepsis in neonates［J］.Drug Evaluat Res,2020,43(12):2493-2497.
［16］　于海芳,纪福利,徐若飞,等.万古霉素治疗新生儿革兰阳性菌败血症的疗效及对患儿生理机能的影响［J］.医学动物防制,2020,36(6):558-560.
YU H F,JI F L,XU R F,et al.Efficacy of vancomycin on neonatal gram-positive bacterial sepsis and its effect on the physiological function of neonates［J］.J Med Pest Control,2020,36(6):558-560.
［17］　张克昌,谢瑞玉,李维春.炎症指标及细胞因子检测在新生儿败血症早期诊断中的应用价值［J］.临床输血与检验,2019,21(4):435-438.
ZHANG K C,XIE R Y,LI W C.Application potential of inflammatory markers and cytokines detection in early diagnosis of neonatal sepsis［J］.J Clin Transfus Lab Med,2019,21(4):435-438.
［18］　冯月华,赵万建,李军华,等.不同病原菌新生儿败血症患儿血糖异常、血小板计数、白细胞计数及C反应蛋白的变化研究［J］.河北医科大学学报,2020,41(4):422-425.
FENG Y H,ZHAO W J,LI J H,et al.Changes of blood glucose,platelet count,white blood cell count and C-reactive protein in children with neonatal sepsis caused by different pathogens［J］.J Hebei Med Univ,2020,41(4):422-425.

更新日期/Last Update: 2022-07-05